New combo radiation aims to cut prostate cancer treatment time

NCT ID NCT06817668

Recruiting now Disease control Sponsor: Indiana University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether a new, shorter course of radiation therapy is safe and tolerable for men with unfavorable or higher-risk prostate cancer. It combines external beam radiation with a single internal radiation boost (brachytherapy). The trial will enroll 31 participants and monitor side effects for 3 months after treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Radiation therapy (external beam and internal brachytherapy)
What this could lead to: If successful, this could offer a shorter, more convenient radiation treatment option for men with higher-risk prostate cancer.
What could go wrong: This is a small, early-phase study (31 people) focused on safety, not effectiveness. The combination may cause more side effects than standard radiation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

Indiana University Melvin and Bren Simon Comprehensive Cancer Center
RECRUITING

Indianapolis, Indiana, 46202, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.